The Plaquex® Formula has been in use for the past 55 years in about one-fourth of the world's countries1. It was originally developed to dissolve fatty embolus during and after trauma surgery. It was also used to treat liver disease2.
In the 1990's the use shifted to treating plaque deposits. The treatment was mostly done in combination with EDTA chelation infusions. Since then results have been so dramatic, that it has become a treatment in its own right.
|Not only is the Plaquex® Formula used to remove fatty and hardened plaque from blood vessels, it is also applied for general anti aging purposes1. By observing their patients, many doctors discovered that the patients started looking younger and healthier after the have had about 20 treatments.|
|In 2006 Plaquex® Oral Gel Capsules were added to the treatment regimen. They improve blood lipids and liver function and thereby aid in the prevention of plaque deposits in between IV treatment sessions.|
|Chosen for their uncompromising quality and superior performance, AnazaoHealth® looks forward to sharing more than a decade of experience with you. Their staff of pharmacists, technicians and account managers are available to answer your questions about preparations, ordering and delivery.|
AnazaoHealth® is fully licensed to provide prescriptions in all 50 states and the District of Columbia. We encourage you to learn more about them by visiting their website at www.anazaohealth.com.
|This website will provide you with help to find basic information, detailed studies, important contact information and to answer frequently asked questions regarding the original Plaquex® product.|
1 Elevation of HDL, LDL, and liver enzymes in
the beginning which normalize with continuing treatment
2 Angina Pectoris
V.K. Klin. Med. (Moscow) 64 (1986) 91-95
J. In: Phosphatidylcholine. H. Peeters (ed.) Springer: Berlin 1976, 237-243
G. et al. Il Fegato 21 (1975) 5-25 and: 4th Int. Sympos.
Atheroscl., Tokyo 1976 and:
G. Scand J. Gastroenterology 12 (1977) 841-847
A.M. Report no. 842276 of March 17, 1975 – and R. Blendin in:
Phosphatidylcholine, H. Peeters (ed.) Springer: